Outset Medical Inc OM.OQ OM.O is expected to show a rise in quarterly revenue when it reports results on August 6 for the period ending June 30 2025
The San Jose California-based company is expected to report a 7.4% increase in revenue to $29.408 million from $27.39 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for Outset Medical Inc is for a loss of 98 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Outset Medical Inc is $23.00, about 34.6% above its last closing price of $15.04
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | -0.92 | -0.94 | -3.24 | Missed | -242.9 |
Dec. 31 2025 | -6.15 | -6.19 | -5.55 | Beat | 10.3 |
Sep. 30 2024 | -6.37 | -6.33 | -5.85 | Beat | 7.5 |
Jun. 30 2024 | -6.76 | -6.78 | -7.05 | Missed | -4.1 |
Mar. 31 2024 | -8.47 | -8.23 | -8.55 | Missed | -3.9 |
Dec. 31 2023 | -9.20 | -9.22 | -8.85 | Beat | 4.1 |
Sep. 30 2023 | -9.98 | -10.00 | -10.65 | Missed | -6.5 |
Jun. 30 2023 | -12.53 | -11.44 | -13.50 | Missed | -18 |
This summary was machine generated August 4 at 20:22 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)